References
- 1. SIEGMANN EM, MÜLLER HHO, LUECKE C, PHILIPSEN A, KORNHUBER J, GRÖMER TW. Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. JAMA Psychiatry 2018;75:577–584.
- 2. ANTONELLI A, FERRARI SM, CORRADO A, DI DOMENICANTONIO A, FALLAHI P. Autoimmune thyroid disorders. Autoimmun Rev 2015;14:174–180.
- 3. TÜREMEN EE, ÇETINARSLAN B, ŞAHIN T, CANTÜRK Z, TARKUN İ. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J 2011;58:349–354.
- 4. VOLPÉ R. The pathology of thyroiditis. Hum Pathol 1978;9:429–438.
- 5. DUNTAS LH, BRENTA G. A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism. Front Endocrinol (Lausanne) 2018;9:511.
- 6. CANARIS GJ, MANOWITZ NR, MAYOR G, RIDGWAY EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–534.
- 7. TAGAMI T, KIMURA H, OHTANI S, TANAKA T, TANAKA T, HATA S, SAITO M, MIYAZAKI Y, ARAKI R, TANAKA M, et al. Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr J 2011;58:449–457.
- 8. VUKOVIC R, ZELJKOVIC A, BUFAN B, SPASOJEVIC-KALIMANOVSKA V, MILENKOVIC T, VEKIC J. Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review. Front Endocrinol (Lausanne) 2019;10:868.
- 9. KIMURA Y, YANAGIDA T, ONDA A, TSUKUI D, HOSOYAMADA M, KONO H. Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation. Arterioscler Thromb Vasc Biol 2020;40:570–582.
- 10. KOCAK MZ, AKTAS G, ERKUS E, SINCER I, ATAK B, DUMAN T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992) 2019;65:9–15.
- 11. AKTAS G, KOCAK MZ, BILGIN S, ATAK BM, DUMAN TT, KURTKULAGI O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male 2019:1–5.
- 12. ZHANG Y-N, WANG Q-Q, CHEN Y-S, SHEN C, XU C-F. Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults. International journal of endocrinology 2020;2020.
- 13. HAMMERSTAD SS, JAHNSEN FL, TAURIAINEN S, HYÖTY H, PAULSEN T, NORHEIM I, DAHL-JØRGENSEN K. Inflammation and increased myxovirus resistance protein A expression in thyroid tissue in the early stages of Hashimoto’s thyroiditis. Thyroid 2013;23:334–341.
- 14. ATAK BM, DUMAN TT, KOCAK MZ, SAVLI H. Serum uric acid level is associated with type 2 diabetes mellitus and diabetic regulation. Experimental Biomedical Research 2018;1:135–139.
- 15. JOHNSON RJ, NAKAGAWA T, SANCHEZ-LOZADA LG, SHAFIU M, SUNDARAM S, LE M, ISHIMOTO T, SAUTIN YY, LANASPA MA. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013;62:3307–3315.
- 16. ISHIZAKA N, ISHIZAKA Y, TODA E, NAGAI R, YAMAKADO M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005;25:1038–1044.
- 17. DEHGHAN A, KÖTTGEN A, YANG Q, HWANG SJ, KAO WL, RIVADENEIRA F, BOERWINKLE E, LEVY D, HOFMAN A, ASTOR BC, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008;372:1953–1961.
- 18. AKTAS G, KOCAK MZ, DUMAN TT, ERKUS E, ATAK BM, SIT M, SAVLI H. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Med J 2018;7:650-653.
- 19. EID BG, NEAMATALLAH T, HANAFY A, EL-BASSOSSY HM, BINMAHFOUZ L, ALDAWSARI HM, HASAN A, EL-AZIZ GA, VEMURI K, MAKRIYANNIS A. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. Molecules 2021;26.
- 20. AKTAS G, ALCELIK A, TEKCE BK, SAVLI H, UYETURK U, KURT M, TEKELIOGLU V, YUCE Y. Mean platelet volume and red cell distribution width in hepatosteatosis. National journal of medical research 2013;3:264–266.
- 21. AKTAS G, DUMAN TT, KURTKULAGI O, TEL BMA, BILGIN S, KAHVECI G, OKU A, KOSEKLI MA. Liver Steatosis is Associated Both with Platelet Distribution Width, Neutrophil/Lymphocyte and Monocyte/Lymphocyte Ratios. Primary Health Care: Open Access 2020;10:1–4.
- 22. KOSEKLI MA, ERKUS E, KOCAK MZ. Mean Platelet Volume to Platelet ratio as a promising marker of hepatosteatosis. Experimental Biomedical Research 2018;1:55–59.
- 23. AKTAS G, SIT M, DIKBAS O, TEKCE BK, SAVLI H, TEKCE H, ALCELIK A. Could red cell distribution width be a marker in Hashimoto’s thyroiditis? Exp Clin Endocrinol Diabetes 2014;122:572–574.
- 24. AKTAS G, SIT M, DIKBAS O, ERKOL H, ALTINORDU R, ERKUS E, SAVLI H. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis. Rev Assoc Med Bras (1992) 2017;63:1065-1068.
- 25. DUNTAS LH. Thyroid disease and lipids. Thyroid 2002;12:287–293.